Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Mai 2026 08:00 ET | Quelle: Science 37, Inc.

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Tufts CSDD completes peer-reviewed analysis of Science 37’s Direct-to-Patient Clinical Trial Site, comparing performance to industry benchmarks.
19. Mai 2026 07:30 ET | Quelle: Vertero Therapeutics, Inc.

Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease

Vertero doses first Parkinson’s patient in Phase 1b study of VT-5006, a gut-selective therapy targeting disease progression.
19. Mai 2026 06:30 ET | Quelle: Avance Clinical

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Meet Avance Clinical's Oncology Center of Excellence expert team at ASCO Annual Meeting in Chicago, held 29 May – 2 June 2026.
18. Mai 2026 08:30 ET | Quelle: Medidata Solutions, Inc.

Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released its second annual report...
15. Mai 2026 06:26 ET | Quelle: Research and Markets

Clinical Trial Agreements Course for CROs, Sponsors and Healthcare Organisations: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)" training has been added to ...
11. Mai 2026 11:24 ET | Quelle: Research and Markets

Gastric Cancer Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Gastric Cancer - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive report presents...
11. Mai 2026 11:21 ET | Quelle: Research and Markets

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive...
11. Mai 2026 11:19 ET | Quelle: Research and Markets

Endometriosis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Endometriosis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
08. Mai 2026 09:51 ET | Quelle: Research and Markets

Clinical Trial Regulatory Requirements (Online Training Course: Sept 14th-15th, 2026) | Understand Regulatory Expectations, Roles, and Responsibilities

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Regulatory Requirements (Sept 14th - Sept 15th, 2026)" training has been added to ResearchAndMarkets.com's offering. Clinical trial...
07. Mai 2026 07:30 ET | Quelle: Annovis Bio Inc.

Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026

MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...

Nächste Seite